← Back to Analyst Consensus 
GUTS Buy
FRACTYL HEALTH, INC.
Current Price —
Implied Upside —
Analysts 13
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 20, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Oct 19, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jul 1, 2026 | Craig-Hallum | initiate | — → Buy | — | 54% |
| Jun 4, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Apr 24, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Mar 26, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jan 30, 2026 | Morgan Stanley | downgrade | Overweight → Equal-Weight | $2 | 54% |
| Dec 2, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Nov 21, 2025 | Canaccord Genuity | maintain | Buy → Buy | $8 | 48% |
| Sep 26, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $8 | 44% |
| Sep 15, 2025 | HC Wainwright & Co. | initiate | — → Buy | $9 | 44% |
| Aug 28, 2025 | Ladenburg Thalmann | initiate | — → Buy | $3.6 | 45% |
| Aug 14, 2025 | Canaccord Genuity | maintain | Buy → Buy | $6 | 48% |
| Apr 15, 2025 | Canaccord Genuity | initiate | — → Buy | $12 | 48% |
| Feb 3, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $10 | 54% |
| Feb 28, 2024 | Evercore ISI Group | initiate | — → Outperform | $0 | 58% |
| Feb 27, 2024 | Morgan Stanley | initiate | — → Overweight | $18 | 54% |
Price Target Trend
May 12, 2026 Oct 26, 2026
EPS Estimates
0q —
0y —
+1y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days